Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Oxiracetam | Piracetam | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 800-2400 mg/day divided into 2-3 doses | 1200-4800 mg/day divided into 2-3 doses |
| Timing | Morning and early afternoon; avoid evening dosing due to mild stimulatory effect. Can be taken with or without food (water-soluble). | With or without food; split doses morning and afternoon to maintain plasma levels |
| Cycle Duration | Cycles of 8-12 weeks on, 4 weeks off | Cycles of 8-12 weeks on, 4 weeks off; or ongoing with periodic reassessment |
| Evidence Level | moderate_human | moderate_human |
Modulates cholinergic neurotransmission by preventing scopolamine-induced decreases of acetylcholine in the hippocampus and cortex. Enhances D-aspartate release and modulates AMPA receptor activity. Demonstrates mild stimulatory properties without affecting dopaminergic or serotonergic systems, making it a 'cleaner' cognitive enhancer among racetams.
800-2400 mg/day divided into 2-3 doses
Morning and early afternoon; avoid evening dosing due to mild stimulatory effect. Can be taken with or without food (water-soluble).
Cycles of 8-12 weeks on, 4 weeks off
Positive allosteric modulator of AMPA receptors, binding at a unique site along the dimer interface to reduce desensitization and deactivation. Inhibits N-type calcium channels at clinically relevant CNS concentrations. Enhances membrane fluidity of neuronal phospholipids and modulates neurotransmission across cholinergic and glutamatergic systems.
1200-4800 mg/day divided into 2-3 doses
With or without food; split doses morning and afternoon to maintain plasma levels
Cycles of 8-12 weeks on, 4 weeks off; or ongoing with periodic reassessment
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →